Linking genes to diseases: it's all in the data

gm77 1756-994X Review Linking genes to diseases: it's all in the data Tiffin Nicki nickitiffin@imaginet.co.za Andrade-Navarro A Miguel Perez-Iratxeta Carolina

MRC/UWC/SANBI Bioinformatics Capacity Development Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellville 7535, South Africa

Max-Delbrück Center for Molecular Medicine, Robert Rössle Strasse 10, 13125 Berlin, Germany

Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada

Genome Medicine 1756-994X 2009 1 8 77 http://genomemedicine.com/content/1/8/77 1967891010.1186/gm77 07 08 2009 2009 BioMed Central Ltd

Abstract

Genome-wide association analyses on large patient cohorts are generating large sets of candidate disease genes. This is coupled with the availability of ever-increasing genomic databases and a rapidly expanding repository of biomedical literature. Computational approaches to disease-gene association attempt to harness these data sources to identify the most likely disease gene candidates for further empirical analysis by translational researchers, resulting in efficient identification of genes of diagnostic, prognostic and therapeutic value. Existing computational methods analyze gene structure and sequence, functional annotation of candidate genes, characteristics of known disease genes, gene regulatory networks, protein-protein interactions, data from animal models and disease phenotype. To date, a few studies have successfully applied computational analysis of clinical phenotype data for specific diseases and shown genetic associations. In the near future, computational strategies will be facilitated by improved integration of clinical and computational research, and by increased availability of clinical phenotype data in a format accessible to computational approaches.

Historically, disease phenotype has informed the selection of candidate disease genes through observations of the effects of perturbations in these candidates in vitro, in tissue cultures and in animal models. This hypothesis-driven approach is increasingly being superseded by genome-wide analyses that assume no prior knowledge of the underlying genotype, and hypotheses about the associated genes are inferred from large-scale genetic studies of samples with the disease phenotype. These studies include genome-wide linkage and association studies in affected and healthy patient populations to identify chromosomal regions most likely to contain etiological genes 123, and the detailed analysis of genome-wide changes in the disease state by high-throughput techniques, such as single nucleotide polymorphism (SNP) 4 and microarray expression analysis 5, serial analysis of gene expression (SAGE) 6 and cap analysis of gene expression (CAGE) 7. Current approaches include next generation sequencing of linked regions, high-density SNP analysis and the study of copy number variation 8.

Typically, genome-wide approaches generate large sets of potential genetic associations for further analysis; for example, multifactorial disease loci identified by linkage analysis can be approximately 30 Mb in size and contain several hundred genes 9. This synergizes with ongoing research on many complex diseases, in which multiple gene variations, rather than single dysfunctional genes, are believed to underlie the disease phenotype 10. Genome-wide analyses have therefore massively increased the number of candidate genes to be investigated for a given phenotype.

Concurrently, available genetic information has increased as a result of more sophisticated experimental methods and centralization of genetic information in public genome databases (such as Ensembl 11, NCBI 12 and UCSC 13), gene expression databases (such as GEO 14) and human variation databases (such as HapMap 15). Additional data on gene regulatory networks and pathways are becoming increasingly accessible (for example, KEGG 16 and Reactome 17). In addition, biomedical literature has become too massive a resource to be assimilated by individuals (for example, 17.8 million abstracts are listed by PubMed in May 2009, of which 10 million deal with human data).

The subsequent challenge is to use this wide variety of data sources to identify relevant disease gene candidates within the lists of genes generated from genome-wide analyses for further empirical research, an overwhelming task to undertake manually. Computational analysis can facilitate efficient and accurate utilization of all such sources of information, and the resulting early prioritization allows streamlined empirical research and quicker and cheaper identification of disease-causing genes.

To date, many computational methods have focused on the prediction of candidates by analysis of inherent sequence characteristics of genes, sequence similarity to known disease genes, and functional annotation of candidate genes 18. These approaches are briefly reviewed here. The computational analysis of phenotypes for the prioritization of disease candidates is less utilized, and is explored later in this article (Figure 1).

Figure 1

Miners in Germany (1952)

Miners in Germany (1952). As with mining of minerals, data mining of associations between genes and diseases can be dirty and disheartening, but the potential for reward is great. Photo: Günther Paalzow. Reproduced from Bundesarchiv, Bild 183-13175-0020 under the Creative Commons Attribution ShareAlike 3.0 license (Germany).

Approaches for the identification of candidate disease genes

Using intrinsic gene properties

By analyzing the intrinsic properties of genes already associated with an inherited disease regardless of its phenotype, differences can be found between disease genes and all human genes. The pattern of differences can be used to predict novel disease genes. Properties associated with disease genes include gene structure, such as longer size of the gene and its associated proteins, and longer regulatory regions such as the mRNA 3' un-translated region (UTR); phylogenetic information, including lower mutation rates, broader phylogenetic breadth and fewer paralogs (that is, fewer highly similar genes giving less opportunity for functional redundancy); and genomic properties such as a higher proportion of CpG islands in promoters and longer intergenic distances.

The first method to apply this type of approach was DGP 19, followed by PROSPECTR 20, which included additional gene properties (for an extensive review of these approaches see 21). Such analyses rely on the definition of genes as 'disease genes' and 'non-disease genes' and, although suited to analysis of monogenic (Mendelian) diseases, such approaches may preclude the selection of genes that do not produce an obvious phenotype but rather contribute to disease susceptibility or the severity of the effect of a simultaneous mutation in another gene. The efficacy of such approaches thus becomes limited in the study of complex phenotypes, in which the association between the gene and disease may not be one of direct or exclusive causation.

Similarity to genes previously associated with disease

Several methods of associating genes with diseases rely on the functional annotation of the gene and, under the hypothesis that similar diseases may have associated genes with similar functions, propose associations on the basis of genes already known to be associated with a disease. This approach is supported by multiple lines of evidence and is a logical way to initiate a search for candidate genes. For example, genes related to the detection or synthesis of neurotransmitters are likely to be good candidates for association with neural disorders, or immune-related genes with asthma and allergy phenotypes.

This is a logical inference, but when there is a growth in the number of gene candidates it becomes difficult to get all the information on known diseases and related literature manually, and computational approaches are helpful. Computational analyses take advantage of both controlled vocabularies describing disease features (such as MeSH terms - an ontology developed at the National Library of Medicine covering different subject categories, including disease phenotype 22) and similarity between gene functions measured by using their annotations with controlled vocabularies, such as the Gene Ontology 23. Methods such as G2D 9, POCUS 24, ENDEAVOUR 25 and TOM 26 use this approach.

A limitation of methods relying on the functional annotations of genes is that just a small percentage of genes in the databases have an experimentally verified function (6% have links to non-genomic literature 27). Most annotation (for approximately 71% of genes 27) is based on functions assumed to associate with predicted protein domains from manually curated databases (such as the Gene Ontology Annotation (GOA) project 28).

Implication of genes in regulatory networks or in protein-protein interaction networks

Information from interactions between genes can be used to find disease-related genes. These data are available from multiple public resources and may describe protein-protein interactions (such as STRING 29 and UniHI 30), proteins regulating gene expression (such as TRANSFAC 31), and metabolic pathways (such as KEGG 16). Some of these categories can overlap to some extent with functional annotations (for example, several genes encoding proteins from the same pathway or protein complex may be described by the same functional annotation comprising a common Gene Ontology term).

The assumption made is that if two genes work together, the known association of one with a disease suggests that the other may also be associated with the same disease. For example, mutations in different subunits of the sarcoglycan complex can result in muscular dystrophy 32. For genes in a regulatory cascade, if the mutation of a gene produces a given phenotype, then mutations in genes further upstream, such as a transcription factor for the downstream gene or a protein kinase that phosphorylates it, could result in the same phenotype. Methods such as ENDEAVOUR 25 and recent versions of G2D 33 exploit this hypothesis.

Gene expression information

The methods described earlier can be complemented using gene expression data. This can be done in relation to the particular disease under analysis (for example selecting genes that are expressed in an affected tissue, such as neural tissue in the case of a neurodegenerative disease); or gene co-expression can be used as another measure of gene similarity to find associations between genes. The second approach is based on the premise that genes acting together will be expressed together, as seen for subunits of protein complexes (such as is described in 212534).

Disease phenotypes

Clinical knowledge is fundamental to defining disease phenotype, and some existing methods aim to make use of this knowledge directly. For example, GeneSeeker 35 is a web tool that uses phenotype search terms input directly by the researcher and filters positional candidate disease genes based on expression and phenotypic data. The Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources (DECIPHER) centralizes clinician-sourced phenotype data and their relationship to copy number variation 36 and is ground-breaking in its aim to make accessible a global wealth of phenotype descriptions submitted directly by clinicians.

Animal models allow in-depth studies of phenotypic variation associated with genes, which are impossible in human subjects (for example, genetic manipulations such as gene knockouts). The data thus generated can be used to associate human genes with phenotypes according to the properties of orthologous genes in such model organisms. In some cases, phenotype association may be in the form of quantitative trait loci (QTLs) involving a number of genes. These methods have to overcome the challenge of identifying the appropriate orthology relations between human and animal genes, which becomes harder with increasing evolutionary distance between the species under study and humans. This approach is used by methods such as GeneSeeker 35 and ToppGene 37 with mouse phenotype data, and Fraser and Plotkin have used a similar approach with yeast data 38.

Some available methods define the disease phenotype in a formalized way that involves the use of existing or customized ontologies. As ontologies are formal representations of a set of concepts within a domain of knowledge and the relationships between those concepts, they are preferable to a definition of the problem phenotype by means of a mere set of keywords provided by the user. Ontologies can facilitate optimal use of available knowledge because many pieces of information can be linked through queries in the databases in which they are used. For example, most of the articles in MEDLINE are annotated with MeSH terms. In this way, they can directly link the phenotype described by a MeSH term to the information contained in the article annotated with it. Phenotype ontologies are used to mine textual databases, such as MEDLINE abstracts in PubMed and/or Online Mendelian Inheritance in Man (OMIM) records, and relate them to gene features and lists of candidate genes. eVOC, a controlled vocabulary for unifying gene expression data, is a purposely developed anatomical ontology that can integrate text mining of biomedical literature and data mining of available human gene expression data 39. The GFINDer method uses an ontology developed from OMIM entries 40. G2D uses disease MeSH terms linked in the OMIM record associated with the phenotype of interest to link phenotypes and Gene Ontology terms 9. PhenoGO, another ontology that assigns phenotypic context to Gene Ontology annotations, also mines the literature to associate phenotypes to Gene Ontology terms 41. A Human Phenotype Ontology has been developed and used to annotate OMIM entries 42, and the broader Mammalian Phenotype Ontology 43 is used in both the Mouse and Rat Genome Databases 4445.

Despite the obvious limitations of transferring information between animal models and humans, the broad range of phenotypic measures that can be obtained from animals is impossible to collect from humans. In the context of complex phenotypes, mice are being predominantly used to study the (usually small) quantitative phenotypic differences associated with a genetic variation (QTLs) 46. Large-scale projects are underway to induce knockouts in mice and analyze the corresponding genotypes by high-throughput techniques 4748. These projects will need extensive and more sophisticated annotation systems such as Phenotype and Trait Ontology (PATO 49), which combines existing phenotype ontologies with phenotype qualities; for example 'insect eye', from the fly anatomy ontology, can bear the quality 'red', giving the combined 'red eye' phenotype.

Application of computational approaches to specific diseases

Only a few studies so far have used phenotype-based computational approaches to identify disease genes and followed this through in patient samples. The GeneSeeker tool was used to prioritize candidates for skeletal dysplasia, and the contribution of a selected candidate to the disease phenotype was demonstrated 50. In this study, linkage analysis identified 77 candidate genes in a 17.1 cM interval. GeneSeeker identified the disease-causing gene as RMRP (an untranslated RNA gene), and its etiological role was confirmed in patients with the disease. Mutations in this gene have been identified previously as disease-causing in milder types of autosomal recessive skeletal dysplasias with differing phenotypes; identification of this additional disease phenotype associated with the gene, however, has furthered understanding of gene function and suggested its involvement in other related disease phenotypes.

The G2D method was used to prioritize candidate genes for asthma and atopy (a type of allergic hypersensitivity) at two previously linked loci in a French Canadian population 51. Ten genes were selected by G2D for a subsequent association study, and SNPs within the candidate genes were genotyped and analyzed using a family-based association test. The results suggested a protective association with allergic asthma for the protein tyrosine phosphatase gene PTPRE in this French Canadian population, although the association could not be replicated in a different cohort 51.

Other than these translational studies, computational analyses have generally been applied to specific diseases and where there are known etiological genes for the disease in question, the accuracy of the results has been assessed by the ranking of these known genes. The candidates that have been flagged as most likely and warranting further empirical research are published for use by the research community, as in our previous studies on candidate genes for metabolic syndrome 52 and type 2 diabetes (T2D) 53. In these, we used multiple computational techniques, including those based on phenotype 3539, for disease gene prioritization, using sets of genes defined by multiple linkage analysis data available through the biomedical literature as starting point.

In the case of metabolic syndrome 52, we initially selected candidates for discrete phenotypes that are associated with the disorder from a starting set of 13,882 genes, and identified candidate genes showing commonality across multiple phenotypes. The phenotype-specific candidates were then weighted according to the prevalence of each phenotype in patient populations, with 19 candidates prioritized as the most likely etiological genes. For T2D, we used multiple computational approaches to identify obesity- and T2D-specific candidates from a starting set of 9,556 positional candidates. This allowed us to generate a final list of nine primary T2D candidates, two of which were also primary candidates for obesity. A SNP in the lipoprotein lipase gene LPL, which was one of the proposed two top candidates, has since been associated with T2D in Korean patients 54.

Similar approaches have been used for other diseases, such as the use of multiple existing computational methods for prediction of genes associated with osteoporosis 55, and the use of extensive phenotype data to select candidate etiological genes for fetal alcohol syndrome56. ENDEAVOUR has also been used to prioritize candidate genes for a variety of phenotypes, reviewed in 25.

Future directions for computational prioritization of candidate disease genes

With increased understanding and availability of human genome and transcriptome data, additional resources can refine the computational prioritization of candidate disease genes. These include data on copy number variation, which has already been used to identify candidate genes for autism 57, and on RNA editing in candidate genes 58. Phenotype can be affected by perturbations in additional elements such as long non-coding genes 59; long range non-coding RNAs, as identified for short stature phenotypes 60 and cancer 61; natural antisense transcripts 62; promoter elements, such as those associated with degenerative heart disease 63; and microRNAs 64. Epidemiological data for disease occurrence used in conjunction with genome-wide data on population variation 65 can facilitate associations between disease phenotypes prevalent in particular populations and their underlying genotypes. Finally, collation and standardization of phenotype data (as undertaken in the DECIPHER project 36) and the further development of phenotype ontologies that have an appropriate degree of granularity and are accessible to scientists are essential for the compilation of clinical phenotype data in a format that allows the computational analysis of associations between disease phenotype and genotype.

Conclusions

Understanding underlying disease genetics is crucial for the development of appropriate disease-specific diagnostic, prognostic and therapeutic approaches, and increasing the efficiency of this process can result in substantial progress in the clinical management of disease. Computational approaches for the identification of disease genes have contributed significantly to our understanding of gene and protein characteristics. These include the tendency of enzymes and transporters to underlie recessive diseases, while transcription regulators and structural molecules often underlie dominant inheritance 19. More generally, they have shown evidence that disease gene function and expression patterns correlate with the type of disease they cause 66. The computational analysis of disease phenotypes has revealed the tendency for similar disease phenotypes to be caused by functionally related genes 67. Such analyses have also shown that the phenotypic similarity between syndromes correlates with the sequence similarity of their associated genes 1868. We believe, however, that there is great scope to better harness clinical phenotypic data to improve computational disease gene prioritization. In an ideal scenario, extensive clinical phenotypic data would be available to computational scientists to use in conjunction with genome-wide empirical data, allowing for effective prediction of most likely disease gene candidates and leading to rapid and economical empirical identification of etiological genes.

For this to become a reality, several objectives need first to be realized. Most importantly, clinical phenotype data need to be routinely standardized in an accessible, patient-anonymous format for computational use. To this end, prospective studies on patient populations could include a computational component at the design stage, so that standardized clinical/phenotypic data can be collected throughout the study. To ensure that this becomes standard practice, however, clinicians need to be convinced of the utility of computational approaches in determining candidate disease genes, and computational studies for specific diseases need to reach the appropriate clinical audience. Collaborative studies between clinical researchers and computational scientists are invaluable in bridging this gap and promoting recognition of computational applications in clinical research, but these are not yet standard practice.

In addition, many computational scientists focus on the development of novel generic approaches for candidate gene prediction for diseases in general. This should not, however, preclude the application of existing methods to specific diseases. Such disease-specific studies, presented in a format accessible to non-computational researchers, would facilitate translation of computational research into the clinical environment and promote recognition of the role of computational studies in disease gene identification.

The ability to investigate the genetics underlying disease phenotypes at a genome-wide level will result in more rapid disease gene identification, as genome-wide analyses can return multiple potential candidate genes simultaneously, rather than verifying or refuting the implication of individual genes in a sequential way. This transition is serendipitous, given that the field of disease genetics is moving on from Mendelian diseases and focusing on complex diseases in which multiple etiological genes are believed to act in concert 69. As increasingly sophisticated techniques uncover the stronger and more frequent gene-disease associations, research techniques will shift towards defining our understanding of more subtle or indirect effects of genes on disease phenotype, in parallel with our increased understanding of the subtleties and complexities of the biological mechanisms of the human cell.

The challenge now lies in finding relevant candidates within the lists of potential disease genes generated from genome-wide approaches. Computational methods are well suited to the systematic analysis of these large gene lists to generate encompassing hypotheses about disease genotype, predict the most likely disease gene candidates from large datasets, and rapidly disseminate the results to clinical researchers performing translational research. Computational disease gene prediction can thus contribute substantially to faster and more cost-efficient empirical identification of disease-causing genes.

Abbreviations

MeSH: Medical Subject Heading; OMIM: Online Mendelian Inheritance in Man; QTL: quantitative trait locus; SNP: single nucleotide polymorphism; T2D: type 2 diabetes.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

NT drafted the initial manuscript and coordinated further work on it. All authors wrote the manuscript and have read and approved the manuscript.

Acknowledgements

MAA-N acknowledges funding support from the Helmholtz Alliance on Systems Biology. NT is supported by the South African Medical Research Council.

Meta-analysis in genome-wide association studies. Zeggini E Ioannidis JP Pharmacogenomics 2009 10 191 201 10.2217/14622416.10.2.191 2695132 19207020 What can genome-wide association studies tell us about the genetics of common disease? Iles MM PLoS Genet 2008 4 e33 10.1371/journal.pgen.0040033 2323402,2323402 18454206 Guilt beyond a reasonable doubt. Altshuler D Daly M Nat Genet 2007 39 813 815 10.1038/ng0707-813 17597768 A new multipoint method for genome-wide association studies by imputation of genotypes. Marchini J Howie B Myers S McVean G Donnelly P Nat Genet 2007 39 906 913 10.1038/ng2088 17572673 Integrating global gene expression analysis and genetics. Farber CR Lusis AJ Adv Genet 2008 60 571 601 full_text 18358333 Deep analysis of cellular transcriptomes - LongSAGE versus classic MPSS. Hene L Sreenu VB Vuong MT Abidi SH Sutton JK Rowland-Jones SL Davis SJ Evans EJ BMC Genomics 2007 8 333 10.1186/1471-2164-8-333 2104538 17892551 Deep cap analysis gene expression (CAGE): genome-wide identification of promoters, quantification of their expression, and network inference. de Hoon M Hayashizaki Y Biotechniques 2008 44 627 628 630, 632. 10.2144/000112802 18474037 The impact of next-generation sequencing technology on genetics. Mardis ER Trends Genet 2008 24 133 141 18262675 Association of genes to genetically inherited diseases using data mining. Perez-Iratxeta C Bork P Andrade MA Nat Genet 2002 31 316 319 12006977 Searching for genetic determinants in the new millennium. Risch NJ Nature 2000 405 847 856 10.1038/35015718 10866211 Ensembl 2008. Flicek P Aken BL Beal K Ballester B Caccamo M Chen Y Clarke L Coates G Cunningham F Cutts T Down T Dyer SC Eyre T Fitzgerald S Fernandez-Banet J Gräf S Haider S Hammond M Holland R Howe KL Howe K Johnson N Jenkinson A Kähäri A Keefe D Kokocinski F Kulesha E Lawson D Longden I Megy K Nucleic Acids Res 2008 36 D707 D714 10.1093/nar/gkm988 2238821 18000006 Database resources of the National Center for Biotechnology Information. Wheeler DL Barrett T Benson DA Bryant SH Canese K Chetvernin V Church DM Dicuccio M Edgar R Federhen S Feolo M Geer LY Helmberg W Kapustin Y Khovayko O Landsman D Lipman DJ Madden TL Maglott DR Miller V Ostell J Pruitt KD Schuler GD Shumway M Sequeira E Sherry ST Sirotkin K Souvorov A Starchenko G Nucleic Acids Res 2008 36 D13 D21 10.1093/nar/gkm1000 2238880 18045790 The UCSC Genome Browser Database: update 2009. Kuhn RM Karolchik D Zweig AS Wang T Smith KE Rosenbloom KR Rhead B Raney BJ Pohl A Pheasant M Meyer L Hsu F Hinrichs AS Harte RA Giardine B Fujita P Diekhans M Dreszer T Clawson H Barber GP Haussler D Kent WJ Nucleic Acids Res 2009 37 D755 D761 10.1093/nar/gkn875 2686463 18996895 NCBI GEO: archive for high-throughput functional genomic data. Barrett T Troup DB Wilhite SE Ledoux P Rudnev D Evangelista C Kim IF Soboleva A Tomashevsky M Marshall KA Phillippy KH Sherman PM Muertter RN Edgar R Nucleic Acids Res 2009 37 D885 D890 10.1093/nar/gkn764 2686538 18940857 A second generation human haplotype map of over 3.1 million SNPs. International HapMap Consortium Frazer KA Ballinger DG Cox DR Hinds DA Stuve LL Gibbs RA Belmont JW Boudreau A Hardenbol P Leal SM Pasternak S Wheeler DA Willis TD Yu F Yang H Zeng C Gao Y Hu H Hu W Li C Lin W Liu S Pan H Tang X Wang J Wang W Yu J Zhang B Zhang Q Nature 2007 449 851 861 10.1038/nature06258 2689609 17943122 KEGG for linking genomes to life and the environment. Kanehisa M Araki M Goto S Hattori M Hirakawa M Itoh M Katayama T Kawashima S Okuda S Tokimatsu T Yamanishi Y Nucleic Acids Res 2008 36 D480 D484 10.1093/nar/gkm882 2238879 18077471 Reactome knowledgebase of human biological pathways and processes. Matthews L Gopinath G Gillespie M Caudy M Croft D de Bono B Garapati P Hemish J Hermjakob H Jassal B Kanapin A Lewis S Mahajan S May B Schmidt E Vastrik I Wu G Birney E Stein L D'Eustachio P Nucleic Acids Res 2009 37 D619 D622 10.1093/nar/gkn863 2686536 18981052 The modular nature of genetic diseases. Oti M Brunner HG Clin Genet 2007 71 1 11 10.1111/j.1399-0004.2006.00708.x 17204041 Genome-wide identification of genes likely to be involved in human genetic disease. Lopez-Bigas N Ouzounis CA Nucleic Acids Res 2004 32 3108 3114 10.1093/nar/gkh605 434425 15181176 Speeding disease gene discovery by sequence based candidate prioritization. Adie EA Adams RR Evans KL Porteous DJ Pickard BS BMC Bioinformatics 2005 6 55 10.1186/1471-2105-6-55 1274252 15766383 Predicting disease genes using protein-protein interactions. Oti M Snel B Huynen MA Brunner HG J Med Genet 2006 43 691 698 10.1136/jmg.2006.041376 2564594 16611749 United States National Library of Medicine, National Institutes of Health, Medical Subject Headings http://www.nlm.nih.gov/mesh/meshhome.html Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Ashburner M Ball CA Blake JA Botstein D Butler H Cherry JM Davis AP Dolinski K Dwight SS Eppig JT Harris MA Hill DP Issel-Tarver L Kasarskis A Lewis S Matese JC Richardson JE Ringwald M Rubin GM Sherlock G Nat Genet 2000 25 25 29 10.1038/75556 10802651 POCUS: mining genomic sequence annotation to predict disease genes. Turner FS Clutterbuck DR Semple CA Genome Biol 2003 4 R75 10.1186/gb-2003-4-11-r75 329128 14611661 ENDEAVOUR update: a web resource for gene prioritization in multiple species. Tranchevent LC Barriot R Yu S Van Vooren S Van Loo P Coessens B De Moor B Aerts S Moreau Y Nucleic Acids Res 2008 36 W377 W384 10.1093/nar/gkn325 2447805 18508807 TOM: enhancement and extension of a tool suite for in silico approaches to multigenic hereditary disorders. Masotti D Nardini C Rossi S Bonora E Romeo G Volinia S Benini L Bioinformatics 2008 24 428 429 10.1093/bioinformatics/btm588 18048394 Towards completion of the Earth's proteome. Perez-Iratxeta C Palidwor G Andrade-Navarro MA EMBO Rep 2007 8 1135 1141 10.1038/sj.embor.7401117 2267224 18059312 The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology. Camon E Magrane M Barrell D Lee V Dimmer E Maslen J Binns D Harte N Lopez R Apweiler R Nucleic Acids Res 2004 32 D262 D266 10.1093/nar/gkh021 308756 14681408 STRING 8 - a global view on proteins and their functional interactions in 630 organisms. Jensen LJ Kuhn M Stark M Chaffron S Creevey C Muller J Doerks T Julien P Roth A Simonovic M Bork P von Mering C Nucleic Acids Res 2009 37 D412 D416 10.1093/nar/gkn760 2686466 18940858 UniHI 4: new tools for query, analysis and visualization of the human protein-protein interactome. Chaurasia G Malhotra S Russ J Schnoegl S Hanig C Wanker EE Futschik ME Nucleic Acids Res 2009 37 D657 D660 10.1093/nar/gkn841 2686569 18984619 The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Wingender E Brief Bioinform 2008 9 326 332 10.1093/bib/bbn016 18436575 Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex. Duggan DJ Hoffman EP Neuromuscul Disord 1996 6 475 482 10.1016/S0960-8966(96)00388-4 9027858 Update of the G2D tool for prioritization of gene candidates to inherited diseases. Perez-Iratxeta C Bork P Andrade-Navarro MA Nucleic Acids Res 2007 35 W212 W216 10.1093/nar/gkm223 1933178 17478516 A human phenome-interactome network of protein complexes implicated in genetic disorders. Lage K Karlberg EO Storling ZM Olason PI Pedersen AG Rigina O Hinsby AM Tumer Z Pociot F Tommerup N Moreau Y Brunak S Nat Biotechnol 2007 25 309 316 10.1038/nbt1295 17344885 GeneSeeker: extraction and integration of human disease-related information from web-based genetic databases. van Driel MA Cuelenaere K Kemmeren PP Leunissen JA Brunner HG Vriend G Nucleic Acids Res 2005 33 W758 W761 10.1093/nar/gki435 1160196 15980578 DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Firth HV Richards SM Bevan AP Clayton S Corpas M Rajan D Van Vooren S Moreau Y Pettett RM Carter NP Am J Hum Genet 2009 84 524 533 10.1016/j.ajhg.2009.03.010 19344873 Improved human disease candidate gene prioritization using mouse phenotype. Chen J Xu H Aronow BJ Jegga AG BMC Bioinformatics 2007 8 392 10.1186/1471-2105-8-392 2194797 17939863 Using protein complexes to predict phenotypic effects of gene mutation. Fraser HB Plotkin JB Genome Biol 2007 8 R252 10.1186/gb-2007-8-11-r252 2258176 18042286 Integration of text- and data-mining using ontologies successfully selects disease gene candidates. Tiffin N Kelso JF Powell AR Pan H Bajic VB Hide WA Nucleic Acids Res 2005 33 1544 1552 10.1093/nar/gki296 1065256 15767279 GFINDer: genetic disease and phenotype location statistical analysis and mining of dynamically annotated gene lists. Masseroli M Galati O Pinciroli F Nucleic Acids Res 2005 33 W717 W723 10.1093/nar/gki454 1160215 15980570 PhenoGO: an integrated resource for the multiscale mining of clinical and biological data. Sam LT Mendonca EA Li J Blake J Friedman C Lussier YA BMC Bioinformatics 2009 10 Suppl 2 S8 10.1186/1471-2105-10-S2-S8 2646241 19208196 The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Robinson PN Kohler S Bauer S Seelow D Horn D Mundlos S Am J Hum Genet 2008 83 610 615 10.1016/j.ajhg.2008.09.017 2668030 18950739 The Mammalian Phenotype Ontology as a tool for annotating, analyzing and comparing phenotypic information. Smith CL Goldsmith CA Eppig JT Genome Biol 2005 6 R7 10.1186/gb-2004-6-1-r7 549068 15642099 The Mouse Genome Database (MGD): mouse biology and model systems. Bult CJ Eppig JT Kadin JA Richardson JE Blake JA Nucleic Acids Res 2008 36 D724 D728 10.1093/nar/gkm961 2238849 18158299 The Rat Genome Database, update 2007 - easing the path from disease to data and back again. Twigger SN Shimoyama M Bromberg S Kwitek AE Jacob HJ Nucleic Acids Res 2007 35 D658 D662 10.1093/nar/gkl988 1761441 17151068 Genome-wide genetic association of complex traits in heterogeneous stock mice. Valdar W Solberg LC Gauguier D Burnett S Klenerman P Cookson WO Taylor MS Rawlins JN Mott R Flint J Nat Genet 2006 38 879 887 10.1038/ng1840 16832355 The European dimension for the mouse genome mutagenesis program. Auwerx J Avner P Baldock R Ballabio A Balling R Barbacid M Berns A Bradley A Brown S Carmeliet P Chambon P Cox R Davidson D Davies K Duboule D Forejt J Granucci F Hastie N de Angelis MH Jackson I Kioussis D Kollias G Lathrop M Lendahl U Malumbres M von Melchner H Müller W Partanen J Ricciardi-Castagnoli P Rigby P Nat Genet 2004 36 925 927 10.1038/ng0904-925 2716028 15340424 A mouse for all reasons. Collins FS Rossant J Wurst W Cell 2007 128 9 13 10.1016/j.cell.2006.12.018 17218247 Phenotypic Quality Ontology, PATO http://obofoundry.org/wiki/index.php/PATO:Main_Page Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. Thiel CT Horn D Zabel B Ekici AB Salinas K Gebhart E Rüschendorf F Sticht H Spranger J Müller D Zweier C Schmitt ME Reis A Rauch A Am J Hum Genet 2005 77 795 806 10.1086/497708 1271388 16252239 Genes to diseases (G2D) computational method to identify asthma candidate genes. Tremblay K Lemire M Potvin C Tremblay A Hunninghake GM Raby BA Hudson TJ Perez-Iratxeta C Andrade-Navarro MA Laprise C PLoS One 2008 3 e2907 10.1371/journal.pone.0002907 2488373 18682798 Prioritization of candidate disease genes for metabolic syndrome by computational analysis of its defining phenotypes. Tiffin N Okpechi I Perez-Iratxeta C Andrade-Navarro MA Ramesar R Physiol Genomics 2008 35 55 64 10.1152/physiolgenomics.90247.2008 18612082 Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes. Tiffin N Adie E Turner F Brunner HG van Driel MA Oti M Lopez-Bigas N Ouzounis C Perez-Iratxeta C Andrade-Navarro MA Adeyemo A Patti ME Semple CA Hide W Nucleic Acids Res 2006 34 3067 3081 10.1093/nar/gkl381 1475747 16757574 Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus. Cho YS Go MJ Han HR Cha SH Kim HT Min H Shin HD Park C Han BG Cho NH Shin C Kimm K Oh B Exp Mol Med 2008 40 523 532 10.3858/emm.2008.40.5.523 2679352 18985010 Prediction of osteoporosis candidate genes by computational disease-gene identification strategy. Huang QY Li GH Cheung WM Song YQ Kung AW J Hum Genet 2008 53 644 655 10.1007/s10038-008-0295-x 18463784 Computational selection and prioritization of candidate genes for fetal alcohol syndrome. Lombard Z Tiffin N Hofmann O Bajic VB Hide W Ramsay M BMC Genomics 2007 8 389 10.1186/1471-2164-8-389 2194724 17961254 Gene-network analysis identifies susceptibility genes related to glycobiology in autism. Zwaag van der B Franke L Poot M Hochstenbach R Spierenburg HA Vorstman JA van Daalen E de Jonge MV Verbeek NE Brilstra EH van 't Slot R Ophoff RA van Es MA Blauw HM Veldink JH Buizer-Voskamp JE Beemer FA Berg van den LH Wijmenga C van Amstel HK van Engeland H Burbach JP Staal WG PLoS ONE 2009 4 e5324 10.1371/journal.pone.0005324 2683930 19492091 Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Li JB Levanon EY Yoon JK Aach J Xie B Leproust E Zhang K Gao Y Church GM Science 2009 324 1210 1213 10.1126/science.1170995 19478186 Long non-coding RNAs: insights into functions. Mercer TR Dinger ME Mattick JS Nat Rev Genet 2009 10 155 159 10.1038/nrg2521 19188922 Long-range conserved non-coding SHOX sequences regulate expression in developing chicken limb and are associated with short stature phenotypes in human patients. Sabherwal N Bangs F Roth R Weiss B Jantz K Tiecke E Hinkel GK Spaich C Hauffa BP Kamp van der H Kapeller J Tickle C Rappold G Hum Mol Genet 2007 16 210 222 10.1093/hmg/ddl470 17200153 Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Clark SJ Hum Mol Genet 2007 16 Spec 1 R88 R95 10.1093/hmg/ddm051 17613553 In search of antisense. Lavorgna G Dahary D Lehner B Sorek R Sanderson CM Casari G Trends Biochem Sci 2004 29 88 94 10.1016/j.tibs.2003.12.002 15102435 Identification of gene co-regulatory modules and associated cis-elements involved in degenerative heart disease. Danko CG Pertsov AM BMC Med Genomics 2009 2 31 10.1186/1755-8794-2-31 2700136 19476647 MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression. Nam S Li M Choi K Balch C Kim S Nephew KP Nucleic Acids Res 2009 37 W356 W362 10.1093/nar/gkp294 2703907 19420067 Genetic variants associated with complex human diseases show wide variation across multiple populations. Adeyemo A Rotimi C Public Health Genomics 2009 doi:10.1159/000218711. 19439916 Highly consistent patterns for inherited human diseases at the molecular level. Lopez-Bigas N Blencowe BJ Ouzounis CA Bioinformatics 2006 22 269 277 10.1093/bioinformatics/bti781 16287936 A similarity-based method for genome-wide prediction of disease-relevant human genes. Freudenberg J Propping P Bioinformatics 2002 18 Suppl 2 S110 S115 12385992 A text-mining analysis of the human phenome. van Driel MA Bruggeman J Vriend G Brunner HG Leunissen JA Eur J Hum Genet 2006 14 535 542 10.1038/sj.ejhg.5201585 16493445 Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Yang Q Khoury MJ Botto L Friedman JM Flanders WD Am J Hum Genet 2003 72 636 649 10.1086/367923 1180239 12592605